Blood Cancer
📧 Sign up to get email alerts when something new happens for Blood Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation [Phase 2]
Open-label Phase II trial evaluating isatuximab for patients with refractory immune cytopenias after allogeneic hematopoietic cell transplan…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years [NA]
A clinical trial evaluating whether Adapted Physical Activity improves sleep quality in children aged 5-16 with cancer; the study is current…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Clinical Evaluation of the Scopio Cell Morphology Technology
A clinical evaluation study of the Scopio Cell Morphology Technology sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCC…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL [Phase 1, Phase 2]
Phase 1/2 trial of MT-3724 in relapsed or refractory diffuse large B-cell lymphoma and related B-cell hematologic malignancies; the study is…
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update on allogeneic transplantation using total lymphoid irradiation and anti-thymocyte globulin in older patients w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]
A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…
-
EMA approval · 2016-06-24New cell-based therapy to support stem cell transplantation in patients with high-risk blood cancer
EMA announces a new cell-based therapy to support stem cell transplantation in patients with high-risk blood cancer, representing a novel tr…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors [Phase 2]
This update notes that a Phase 2 online survivorship workshop study sponsored by Stanford University has completed for cancer survivors, inc…
-
FDA approval ·FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
FDA approves TREGZI, the first regulatory T cell–based immunotherapy to improve chronic GVHD-free survival in adults undergoing allo-HSCT fo…